New combo therapy shows promise for HPV throat cancer patients
NCT ID NCT01932697
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a treatment for people with HPV-related throat cancer. It combined a higher dose of radiation with the chemotherapy drug docetaxel. The goal was to see if this approach could better control the tumor and improve survival. The study involved 81 participants and was completed by the Mayo Clinic.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gel that could help the cervix heal from HPV?
- A Two-Pronged immune attack against HPV: could it prevent cervical cancer?
- Better swab, better catch: study aims to sharpen anal cancer screening
- HPV vaccine trial aims to protect women with HIV from cervical cancer
- New strategies help more teens get HPV vaccine
- Education boosts HPV vaccine willingness in women, study hopes